All lobbying filings

BRIDGEBIO PHARMA, INC.

Lobbying for BRIDGEBIO PHARMA, INC. · Biotech company

Filing 4th Quarter - Amendment

4th Quarter (Oct 1 - Dec 31) 2024 · California · House · Senate · $330,000.00 expenses · posted Jul 17, 2026

Official filing document

Bills named in this filing 5

HR 7384
Creating Hope Reauthorization Act of 2024
HR 3433
Give Kids a Chance Act of 2024
S 4583
Creating Hope Reauthorization Act of 2024
HR 9979
Scientific EXPERT Act of 2024
HR 10545
American Relief Act, 2025

Lobbying activity 1

Pharmacy

Creating Hope Reauthorization Act of 2024 - H.R. 7384 Give Kids a Chance Act of 2024 - H.R. 3433 Creating Hope Reauthorization Act of 2024 - S. 4583 March-in/Bayh-Dole Act Orphan drug policies Scientific EXPERT Act of 2024 - H.R.9979 H.R.9979 - Scientific EXPERT Act of 2024 H.R.10545 - American Relief Act, 2025

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.